Editorial overview: Clinical utility of synergy testing for multidrug resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis

Paediatric Respiratory Reviews

Volumn 8, Issue 3, 2007, Pages 262-264

  Middleton, Peter G ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL TRIAL; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG CHOICE; DRUG TREATMENT FAILURE; EDITORIAL; GRAM NEGATIVE INFECTION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE;

ANTI-BACTERIAL AGENTS; BACTERIA; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 34548854518     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2007.08.003     Document Type: Editorial

References (2)

1. Middleton P.G., Kidd T.J., and Williams B. Combination aerosol therapy to treat Burkholderia cepacia complex. Eur Respir J 26 (2005) 305-308
2. Aaron S.D., et al. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial. Lancet 366 (2005) 463-471